Pharma & Biotech

MedNews is a FREE SERVICE of Medical and Pharma Insider in conjunction with BCI News Service.

To have your company news featured at Medical and Pharma Insider, please visit www.bcinewsservice.com.

View our disclaimer/disclosure

Featuring MedNews and MedTalks Videos, video conversations with management of medical, pharma, biopharma, healthcare, telemedicine, and medical device companies.

4 days ago
3 min

Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome

Aqualung is an early-stage biotech company developing immune-focused therapeutic platform, eNamptor™.

5 days ago
2 min

SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects

Our team is addressing two core issues with our proprietary technology: enhancing bioavailability and reducing development time.

Sep 3
5 min

Early-stage novel cell therapy company Neukio Biotherapeutics closes a $50 million financing

The transition from traditional small molecules and antibodies to the era of cell therapy is a great leap in drug design and manufacturing

Sep 1
3 min

OKYO plans fourth quarter IND filing for drug candidate to treat dry eye disease

OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO) is a life sciences and biotechnology company recently listed on Nasdaq .

Aug 20
1 min

Laos-based pharmaceutical company BioSpring completes phase 1 of manufacturing facility

BioSpring is a vertically integrated pharmaceutical company providing solutions from formulation development to product commercialization.

Aug 13
2 min

Clario invests in new technology to reduce translation times for clinical trials

For nearly 50 years, Clario has been delivering the leading endpoint technology solutions for clinical trials.

Aug 5
2 min

Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy

Immunis’ FDA Phase 1/2a clinical trial is a study to assess IMM01-STEM in elderly participants with muscle atrophy.

Aug 3
3 min

IDRx raises $122 million to transform cancer treatment with precision combination therapies

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies.

Jul 30
3 min

Ozette closes on $26 million to advance its AI-Powered Single-Cell Immune Discovery Technology

The new funding will fuel company growth and enable Ozette to expand its capabilities across a multiomic platform

Jul 27
3 min

PCI Pharma Services to expand it’s UK manufacturing capability for manufacturing oncology treatments

The expansion includes two new facilities dedicated to the manufacturing and packaging of solid oral-dose tablets and capsules.

Jul 15
3 min

Manifold Bio Raises $40 Million for its next-generation protein engineering platform

Manifold Bio is a fully-integrated biotechnology company pursuing a pipeline of targeting-enhanced protein therapeutics.

Jul 9
4 min

Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology

There’s a major unmet need to improve outcomes for cancer patients and Kernal Bio has built a strong rational for the use of its novel mRNA

Jul 5
2 min

Mindset Pharma develops an intranasal platform for psychedelic medicines

Mindset Pharma is focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological disorders.

Jul 1
3 min

Twist Bioscience and Ildong Pharmaceutical Collaborate on Antibody Discovery for Immuno-oncology

Under the terms of the agreement, Ildong will license a suite of Twist’s VHH libraries for a period of three years.

Jun 24
3 min

Eton Pharmaceuticals sells its hospital products to Dr. Reddy’s Laboratories for $50 million

Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.

Jun 23
2 min

A2W Pharma and MedC Biopharma Partner to develop Cannabinoid Therapeutics

A2W is a subsidiary of Amino Chemicals of Malta, which is a subsidiary of ABA Chemicals of China, a global pharmaceutical company.

Jun 12
2 min

Degron Therapeutics Raises $22 Million for its Molecular-Glue-Based Targeted Protein Degradation

The company’s pipeline includes a growing number of preclinical compounds for oncology, inflammation, metabolic disease, and rare diseases.

Jun 8
3 min

L7 Informatics Raises $38 Million to Accelerate Innovation in Precision Healthcare

Over the last decade, personalized healthcare has spread beyond oncology and now comprises almost half of all new drugs in development.

Jun 7
2 min

OriCiro Closes on Financing to Advance Cell-Free Cloning technology for Large Circular DNA

OriCiro Genomics’ unique cell-free DNA technology has a tremendous potential for business applications, particularly for healthcare.

Jun 5
3 min

Imaging Endpoints and ImaginAb partner to supply doses of the CD8 imaging agent for clinical trials

Imaging Endpoints is the world’s largest oncology-focused imaging CRO and has partnered with ImaginAb over the past decade.